InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
11
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-20.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Lehr Martin A., Chief Executive Officer. Insider active across 1 company, notably Context Therapeutics Inc.. Cumulatively, 12 reports have been logged. Breakdown: 11 buys · 0 sell. Total volume traded: €207k. History available since 22 October 2021. The latest transaction was filed on 9 June 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lehr Martin A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
100,000 shares@ US$0.700811.6% of flowCommon StockSEC:0001842952-25-000064:0
Canonical exit: 7 Sept 2025 (T+90)
5,823 shares@ US$0.84150.5% of flowCommon StockSEC:0001842952-23-000030:0
Canonical exit: 22 May 2023 (T+90)
5,606 shares@ US$0.87420.5% of flowCommon StockSEC:0001842952-23-000020:0
Canonical exit: 14 May 2023 (T+90)
5,040 shares@ US$0.97230.5% of flowCommon StockSEC:0001842952-23-000017:0
Canonical exit: 7 May 2023 (T+90)
7,027 shares@ US$0.69740.5% of flowCommon StockSEC:0001842952-23-000012:0
Canonical exit: 30 Apr 2023 (T+90)
6,839 shares@ US$0.71660.5% of flowCommon StockSEC:0001842952-23-000008:0
Canonical exit: 23 Apr 2023 (T+90)
6,783 shares@ US$0.73640.5% of flowCommon StockSEC:0001842952-23-000006:0
Canonical exit: 17 Apr 2023 (T+90)
20,000 shares@ US$0.73981.6% of flowCommon StockSEC:0001842952-22-000112:0
Canonical exit: 16 Mar 2023 (T+90)
13,000 shares@ US$1.85112.7% of flowCommon StockSEC:0001842952-22-000081:0
Canonical exit: 17 Nov 2022 (T+90)
13,000 shares@ US$3.21927.0% of flowCommon StockSEC:0001842952-21-000029:0
Canonical exit: 16 Mar 2022 (T+90)
52,680 shares@ US$7.1461.0% of flowCommon StockSEC:0001842952-21-000027:0
10,000 shares@ US$5.008.1% of flowCommon StockSEC:0001179110-21-009609:0
Canonical exit: 20 Jan 2022 (T+90)
12 of 12 declarations
About Lehr Martin A.
Lehr Martin A. is Director General and Chief Executive Officer of Context Therapeutics Inc. He has 12 filings in total, and in the 12 sampled filings the purchases total EUR 206501, with no sales, over the period from 2021-10-25 to 2025-06-10, with the transaction nature listed as Acquisition.
